| 标题： | 肝细胞癌伴微血管侵犯诊断和治疗中国专家共识(2024年版) |
| title： | Chinese expert consensus on diagnosis and treatment of hepatocellular carcinoma with microvascular invasion(2024) |
| 版本： | 原创版 |
| version： | Original |
| 分类： | 专家共识 |
| classification： | Experts consensus |
| 领域： | 诊疗 |
| field： | Diagnosis and Treatment |
| 国家和地区： | 中国 |
| Country and region： | China |
| 指南使用者： | 各等级医院从事肝癌相关工作的临床医师、技术人员及相关教学、科研工作人员 |
| Guide users： | Clinicians, technicians and related teaching and research staff engaged in liver cancer related work in hospitals of all levels |
| 证据分级方法： | Ia 证据源于对多项随机对照研究的Meta分析结果 Ib 证据源于至少一项设计良好的随机对照研究结果 IIa 证据源于至少一项设计良好的前瞻性非随机对照研究结果 IIb 证据源自至少一项设计良好的其他类型干预性临床研究结果 III 证据源于设计良好的非干预性研究，如描述性研究，相关性研究等 IV 证据源于专家委员会报告或权威专家的临床经验报道 |
| Evidence grading method： | Ia Evidences are originated from the meta-analysis results of various RCTs Ib Evidences are originated from the results of at least one well-designed RCT IIa Evidences are originated from the results of at least one well-designed perspective non-RCT IIb Evidences are originated from the results of at least one well-designed interventional clinical research of other type III Evidences are originated from the well-designed non-interventional clinical researches, such as descriptive researches and relevant researches IV Evidences are originated from the reports made by committee of experts or the clinical reports of authoritative experts |
| 制定单位： | 中国医师协会肝癌专业委员会 |
| Formulating unit： | Chinese Association of Liver Cancer(CALC) and Chinese Medical Doctor Association(CMDA) |
| 注册时间： | 2024-01-18 |
| Registration time： | |
| 注册编号： | PREPARE-2024CN185 |
| Registration number： | |
| 指南制订的目的： | 目前国际上对于MVI的诊断、分型、预测及治疗仍存在较多争议，尚未达成共识。中国医师协会肝癌专业委员会基于现有的循证医学证据，尤其是我国学者针对肝癌伴MVI取得的临床研究成果，经共识委员会成员反复讨论，形成本共识。 |
| Purpose of the guideline： | At present, there are still many controversies on the diagnosis, classification, prediction and treatment of MVI, and no consensus has been reached. Based on the existing evidence-based medical evidence, especially the clinical research results of Chinese scholars on HCC with MVI, the CALC reached this consensus after repeated discussion by members of the CALC. |
